Attentional dysfunction and the punding spectrum in Parkinson's disease
Year: 2021
Type: article
Source: Parkinsonism & Related Disorders
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Michael J. Fox Foundation for Parkinson's Research, National Parkinson Foundation, Pfizer, GlaxoSmithKline, Roche, Teva Pharmaceutical Industries, AbbVie, Northwestern University, Takeda Pharmaceuticals U.S.A., ACADIA Pharmaceuticals, Voyager Therapeutics, Servier, National Institutes of Health, Allergan, School of Public Health, University of California Berkeley, Sanofi Genzyme, National Institute on Aging, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences
Awards: Astrocyte NLRP3 inflammasome activation in Parkinson's disease, Institute for Clinical and Translational Research, Medical Scientist Training Program, Anxiety in Parkinson's: Use of quantitative methods to guide rational treatment, G7821276989, Molecular Imaging of the Nicotinic Cholinergic Receptor in Parkinson's disease (PD): Implication of for understanding the neurobiology of cognitive impairment, Medical Scientist Training Program
OpenAlex ID: W3126737697